Back to search results

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Abroad (travel likely)Recruiting

Conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease · Hepatocellular Carcinoma · Metabolic Dysfunction-Associated Steatohepatitis · Liver Transplant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy

    Contact: Study coordinator (Fabio Piscaglia, Prof, MD) · fabio.piscaglia@unibo.it · +39 051 2142542
    Contact: Study coordinator (Mariarosaria Marseglia, Dr.) · mariarosaria.marseglia@aosp.bo.it · +39 0512142477
    Contact: Principal Investigator (Fabio Piscaglia, Prof., MD)
    Federico Ravaioli, MD, PhD (Sub-investigator)
    Silvia Ferri, MD, PhD (Sub-investigator)
    Bernardo Stefanini, MD, PhD (Sub-investigator)
Study leads

  • Fabio Piscaglia, Prof, MD

    Principal Investigator

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

View source on ClinicalTrials.gov(opens in a new tab)